Data from EMA (European Medicines Agency) - Curated by Toby Galbraith - Last updated 10 August 2017

Indication(s)

Infanrix hexa is indicated for primary and booster vaccination of infants and toddlers against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by Haemophilus influenzae type b.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

+ 1 more

Visit Prostate Cancer

Related Content

More information

Category Value
Agency product number EMEA/H/C/000296
Orphan designation No
Date First Approved 23-10-2000
Type Medicinal product subject to medical prescription
Marketing authorisation holder GlaxoSmithKline Biologicals S.A.